Last reviewed · How we verify

NCT03184896: HiFit

Services Mapping Among Older Adults With Hip Fracture

Status unknown Last updated 5 February 2020
What this trial tests

trial testing Hip Fracture Surgery in Hip Fractures in 2,500 participants. Status unknown.

Timeline
14 November 2018
Primary endpoint
13 November 2021
13 November 2021

Quick facts

Lead sponsorThe George Institute for Global Health, China
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment2,500
Start date14 November 2018
Primary completion13 November 2021
Estimated completion13 November 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The George Institute for Global Health, China

Who can join

65 and older, any sex, with Hip Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hip fracture is a osteoporosis-related fracture with higher mortality, and is a major public health issue in China. The British Orthopedic Association and the British Geriatric Society have published the UK Blue Book, which summarizes current evidence and best practice in the hip fracture care and secondary prevention, but this kind of standardized practice in hip fracture care is not yet existed in China. The Blue Book standards will be used as the most contemporary evidence-based guidelines for management of hip fracture.This study is to prospectively examine the barriers and facilitators in the current management of hospital in China by comparing the Blue Book standards.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The effectiveness of a co-management care model on older hip fracture patients in China - A multicentre non-randomised controlled study.
    Zhang J, Yang M, Zhang X, He J, et al · · 2022 · cited 41× · PMID 35141666 · DOI 10.1016/j.lanwpc.2021.100348
  2. Effect of the orthogeriatric co-management on older hip fracture patients with multimorbidity: a post-hoc exploratory subgroup analysis of a non-randomised controlled trial.
    Liu T, Zhang X, Zhang J, Ye P, et al · · 2024 · cited 25× · PMID 39574198 · DOI 10.1186/s13018-024-05263-0
  3. Orthogeriatric co-managements lower early mortality in long-lived elderly hip fracture: a post-hoc analysis of a prospective study.
    Gao F, Liu G, Ge Y, Tan Z, et al · · 2023 · cited 12× · PMID 37723423 · DOI 10.1186/s12877-023-04289-z
  4. Prognostic nutritional index (PNI) is an independent predictor for functional outcome after hip fracture in the elderly: a prospective cohort study.
    Chen Y, Bei M, Liu G, Zhang J, et al · · 2024 · cited 9× · PMID 39499371 · DOI 10.1007/s11657-024-01469-1
  5. Association between admission inflammatory indicators and 3-year mortality risk in geriatric patients after hip fracture surgery: a retrospective cohort study.
    Chen Y, Tu C, Liu G, Peng W, et al · · 2024 · cited 8× · PMID 39229251 · DOI 10.3389/fsurg.2024.1440990
  6. Prognostic Nutritional Index (PNI) as an Independent Predictor of 3-Year Postoperative Mortality in Elderly Patients with Hip Fracture: A Post hoc Analysis of a Prospective Cohort Study.
    Chen Y, Liu G, Zhang J, Ge Y, et al · · 2024 · cited 8× · PMID 39142664 · DOI 10.1111/os.14200
  7. Association Between Hip Bone Mineral Density and Mortality Risk After Hip Fracture: A Prospective Cohort Study.
    Ge Y, Chen Y, Liu G, Zhu S, et al · · 2023 · cited 7× · PMID 37347299 · DOI 10.1007/s00223-023-01109-9
  8. Immediate weight bearing as tolerated versus delayed weight bearing following intramedullary fixation for geriatric intertrochanteric fractures: a post hoc analysis.
    Li N, Cheng KY, Zhang J, Liu G, et al · · 2024 · cited 3× · PMID 39702062 · DOI 10.1186/s12891-024-08172-9

Verify or expand the search:

Other trials of Hip Fracture Surgery

Trials testing the same drug.

Other recruiting trials for Hip Fractures

Currently open trials in the same condition.

Other The George Institute for Global Health, China trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03184896.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing